Integral Diagnostics Limited (ITGDF)
- Previous Close
0.0000 - Open
2.1000 - Bid 0.5100 x --
- Ask 3.1500 x --
- Day's Range
2.1000 - 2.1000 - 52 Week Range
2.1000 - 2.1000 - Volume
100 - Avg. Volume
0 - Market Cap (intraday)
782.103M - Beta (5Y Monthly) 0.26
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1600 - Earnings Date Feb 25, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Mar 6, 2025
- 1y Target Est
--
Integral Diagnostics Limited, a healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. It provides positron emission tomography, magnetic resonance imaging, and other radiology services. The company was founded in 1967 and is headquartered in Melbourne, Australia.
www.integraldiagnostics.com.au1,977
Full Time Employees
June 30
Fiscal Year Ends
Sector
Industry
Recent News: ITGDF
View More
Performance Overview: ITGDF
Trailing total returns as of 5/6/2025, which may include dividends or other distributions. Benchmark is S&P/ASX 200 [XJO] (^AXJO) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ITGDF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ITGDF
View MoreValuation Measures
Market Cap
573.58M
Enterprise Value
896.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
1.15%
Return on Assets (ttm)
2.57%
Return on Equity (ttm)
1.14%
Revenue (ttm)
491.32M
Net Income Avi to Common (ttm)
5.66M
Diluted EPS (ttm)
-0.1600
Balance Sheet and Cash Flow
Total Cash (mrq)
31.26M
Total Debt/Equity (mrq)
76.84%
Levered Free Cash Flow (ttm)
66.46M